Provided by Tiger Trade Technology Pte. Ltd.

Kiora Pharmaceuticals

2.08
-0.0550-2.58%
Volume:15.77K
Turnover:33.16K
Market Cap:7.65M
PE:-1.01
High:2.13
Open:2.13
Low:2.06
Close:2.14
52wk High:4.18
52wk Low:1.76
Shares:3.68M
Float Shares:3.39M
Volume Ratio:0.74
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0517
EPS(LYR):0.9282
ROE:-32.58%
ROA:-17.07%
PB:0.34
PE(LYR):2.24

Loading ...

Kiora Pharmaceuticals Granted U.S. Patent for Novel KIO-104 Anti-Inflammatory Formulations

Reuters
·
Dec 01

Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating

TIPRANKS
·
Nov 12

Kiora Pharmaceuticals Reports Improved Financial Performance

TIPRANKS
·
Nov 11

Kiora Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 07

Kiora Pharmaceuticals Q3 EPS $0.01 May Not Be Comparable To $(0.66) Estimate

Benzinga
·
Nov 07

Kiora Pharmaceuticals posts third quarter results and reports ongoing Phase 2 trials for retinal diseases

Reuters
·
Nov 07

Kiora Pharmaceuticals Inc expected to post a loss of 73 cents a share - Earnings Preview

Reuters
·
Nov 04

BRIEF-Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing

Reuters
·
Sep 16

Kiora Pharmaceuticals Inc : Files for Mixed Shelf Offering of up to $100 Mln- SEC Filing

THOMSON REUTERS
·
Sep 16

Kiora Pharmaceuticals Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 02

Kiora Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Aug 08

Kiora Pharmaceuticals Q2 EPS $(0.54) Beats $(0.60) Estimate

Benzinga
·
Aug 08

Kiora Pharmaceuticals Reports Consistent Q2 Net Loss of $2.2 Million; R&D Expenses Rise Due to Clinical Trials

Reuters
·
Aug 08

Kiora Pharmaceuticals Inc expected to post a loss of 60 cents a share - Earnings Preview

Reuters
·
Aug 05

Vicarious Surgical Inc. Appoints Stephen From as New CEO Amid Leadership Transition

Reuters
·
Aug 01

Kiora Pharmaceuticals Secures U.S. Patent for KIO-104, Enhancing Protection for Ocular Disease Treatment

Reuters
·
Jul 22